Product information and disease descriptionPlace of product in therapyDisease description
Epidemiology
14 evidence topics · 8 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionPlace of product in therapyDisease description
14 evidence topics · 8 sources